Clinical trial
Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III…
NCT00004050 · Vical, Industry · Terminated
Key facts
| NCT number | NCT00004050 |
|---|---|
| Title | Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer |
| Official title | Phase II Study Evaluating the Safety and Efficacy of Neoadjuvant Leuvectin Immunotherapy for the Treatment of Prostate Cancer |
| Lead sponsor | Vical, Industry |
| Collaborators | Jonsson Comprehensive Cancer Center National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological |
| Interventions | Leuvectin |
| Enrollment | 13 |
| Start date | Jun 1, 1999 |
| Primary completion | Apr 1, 2003 |
| Completion | Apr 1, 2003 |
| First posted | Oct 29, 2003 |
| Last update posted | Jul 29, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: